https://xconomy.com/national/2019/12/03/a-safer-crispr-cyrus-broad-institute-look-to-quell-concerns/

https://www.fiercebiotech.com/biotech/cyrus-broad-team-up-to-make-vivo-crispr-use-safer

https://www.geekwire.com/2019/cyrus-biotechnology-teams-crispr-pioneers-boost-gene-editing-therapies/

CAMBRIDGE, Mass. & SEATTLE — Cyrus Biotechnology, Inc., and the Broad Institute of MIT and Harvard have embarked on a scientific collaboration to optimize CRISPR for use in developing novel human therapeutics. …

Abstract: The voltage-gated potassium channel KCNQ1 (KV7.1) assembles with the KCNE1 accessory protein to generate the slow delayed rectifier current, IKS, which is critical for membrane repolarization as part of the cardiac …